MCAT · Cells and Cellular Organization

Cytoskeleton Structure and Cell Motility (2A)

How microfilaments, intermediate filaments, and microtubules orchestrate cell shape, intracellular transport, and motility.

MCAT emblem with a laboratory flask, DNA, and a brain.
Inside this lesson 10 sections 5 questions 8 figures

SECTION 1

Historical Context & Motivation

The concept of a structured internal scaffold within eukaryotic cells emerged gradually over the twentieth century, driven by advances in microscopy and biochemical fractionation. Early light microscopists observed thread-like structures in dividing cells, yet the prevailing view treated cytoplasm as an amorphous colloidal gel with little organizational significance. The discovery that cells possess a dynamic, protein-based cytoskeleton capable of rapid assembly and disassembly fundamentally reshaped our understanding of cell biology, providing the mechanistic basis for phenomena as varied as muscle contraction, chromosomal segregation during mitosis, and amoeboid migration of immune cells toward sites of infection.

1944 • Discovery of Actin

Albert Szent-Györgyi and colleagues isolated actin and myosin from rabbit skeletal muscle, demonstrating that their interaction generated contractile force in vitro, laying the biochemical foundation for understanding microfilament-based motility.

1963 • Visualization of Microtubules

Using electron microscopy, Ledbetter and Porter visualized microtubules as hollow cylindrical structures in plant cells, establishing their existence as a distinct cytoskeletal element separate from microfilaments.

1978 • Intermediate Filament Classification

Lazarides and colleagues systematically classified intermediate filaments (IFs) as a third cytoskeletal system with a diameter of approximately 10 nm, intermediate between actin filaments and microtubules, and demonstrated their role in mechanical resilience.

1985 • Motor Protein Kinesin Identified

Vale, Reese, and Sheetz identified kinesin as an ATP-dependent motor that translocates vesicles along microtubules toward the plus end, complementing the earlier characterization of cytoplasmic dynein as a minus-end–directed motor.

2000s • Live-Cell Imaging Revolution

GFP-tagged cytoskeletal proteins and total internal reflection fluorescence (TIRF) microscopy permitted real-time visualization of filament dynamics, revealing the stochastic nature of dynamic instability and treadmilling in living cells.

These discoveries collectively raised a central question that remains at the heart of MCAT-level cell biology: how do three distinct polymer systems—microfilaments, intermediate filaments, and microtubules—cooperate with associated motor and regulatory proteins to generate the forces and structural frameworks that underlie cell shape, division, intracellular transport, and whole-cell motility? Answering this question requires an integrated understanding of polymer biochemistry, nucleotide hydrolysis–driven dynamics, and mechanical transduction—topics we will systematically develop in the sections that follow.

SECTION 2

Core Principles & Definitions

The eukaryotic cytoskeleton comprises three principal polymer networks, each assembled from distinct protein subunits, each possessing unique mechanical properties, and each regulated by a characteristic set of accessory proteins. Despite their differences, the three systems share a unifying design principle: noncovalent self-assembly of monomeric or oligomeric subunits into polar or nonpolar filaments whose formation and disassembly can be rapidly controlled to reshape the cell in response to intracellular and extracellular signals.

1

Microfilaments (Actin Filaments)

Composed of G-actin monomers (≈ 42 kDa) that polymerize into helical F-actin filaments approximately 7 nm in diameter. Polar structures with a fast-growing barbed (+) end and a slow-growing pointed (−) end. Undergo treadmilling powered by ATP hydrolysis. Critical for cell cortex integrity, lamellipodia, filopodia, contractile rings, and interaction with myosin motors.
2

Microtubules

Hollow cylinders (≈ 25 nm outer diameter) assembled from heterodimers of α-tubulin and β-tubulin arranged into 13 protofilaments. Exhibit dynamic instability—stochastic switching between growth and rapid catastrophic shrinkage driven by GTP hydrolysis in the β-tubulin subunit. Nucleated from the centrosome (MTOC). Essential for mitotic spindle, vesicle trafficking via kinesin and dynein, and cilia/flagella.
3

Intermediate Filaments

Rope-like polymers (≈ 10 nm diameter) assembled from tissue-specific proteins such as keratins (epithelial), vimentin (mesenchymal), neurofilaments (neurons), and lamins (nuclear envelope). Nonpolar and do not require nucleotide hydrolysis for assembly. Provide tensile strength and resist mechanical stress.
4

Motor Proteins

ATP-hydrolyzing enzymes that convert chemical energy into directional mechanical work along cytoskeletal tracks. Myosins walk on actin filaments; kinesins are predominantly plus-end–directed microtubule motors; dyneins are minus-end–directed microtubule motors. Together they drive vesicular transport, spindle assembly, and ciliary beating.
5

Polarity & Dynamic Regulation

Structural polarity of actin filaments and microtubules provides directionality for motor protein movement and asymmetric growth kinetics. Regulatory proteins—including Arp2/3 complex, formins, cofilin, and MAPs (microtubule-associated proteins)—fine-tune polymerization, severing, cross-linking, and capping to modulate cellular architecture in real time.
✦

KEY TAKEAWAY

Think of the cytoskeleton as a city's infrastructure system operating at three scales. Microfilaments are the local roads and sidewalks at the cell periphery, dynamically rerouted for pedestrian (signal-directed) traffic. Microtubules are the interstate highways radiating from a central hub (the centrosome), carrying long-haul cargo via motor protein 'trucks.' Intermediate filaments are the steel girders and cables that give buildings structural integrity, resisting forces that would deform or rupture the cell. No single system is sufficient alone; it is their coordinated interplay that sustains cellular form and function.

SECTION 3

Visual Overview: Cytoskeletal Systems Compared

Three Cytoskeletal Polymer SystemsMICROFILAMENTS≈ 7 nm diameterG-actinmonomers(+) Barbed end(−) Pointed endKey Features:• ATP-dependent assembly• Treadmilling• Polar (+ / − ends)• Two-stranded helixMotor: MyosinFunctions:Cell cortex, lamellipodia,contractile ring, microvilliMICROTUBULES≈ 25 nm diameterα-tubulinβ-tubulin(+) end(−) endKey Features:• GTP-dependent assembly• Dynamic instability• Polar (+ / − ends)• 13 protofilamentsMotors: Kinesin / DyneinFunctions:Mitotic spindle, vesicletransport, cilia, flagellaINTERMEDIATE FILAMENTS≈ 10 nm diameterCoiled-coil dimers →antiparallel tetramers →rope-like filamentKey Features:• No nucleotide required• Nonpolar• Tissue-specific types• Very stable assembliesNo associated motorFunctions:Mechanical strength,nuclear lamina, desmosomes
Comparison of the three cytoskeletal polymer systems. Microfilaments (left) are thin, helical, and polar with ATP-dependent dynamics. Microtubules (center) are hollow cylinders of αβ-tubulin dimers with GTP-dependent dynamic instability. Intermediate filaments (right) are nonpolar, rope-like structures assembled without nucleotide hydrolysis.

The diagram above provides a structural overview of the three cytoskeletal systems, arranged by increasing diameter from left to right. Notice that both microfilaments and microtubules possess intrinsic structural polarity—a plus end where net assembly is faster and a minus end where net disassembly predominates under steady-state conditions. This polarity is critical because it determines the directionality of motor protein movement. Intermediate filaments, by contrast, assemble from antiparallel tetramers, rendering the resulting filament nonpolar and therefore incompatible with directional motor transport. Instead, IFs function primarily as passive mechanical scaffolds, contributing tensile strength analogous to steel reinforcement rods within concrete.

SECTION 4

Polymerization Dynamics & Motor Protein Mechanisms

Actin Treadmilling

In the phenomenon of treadmilling, actin monomers bound to ATP preferentially add to the barbed (+) end, while ADP-bound subunits dissociate from the pointed (−) end. This directional flux of subunits through the filament produces net movement of the polymer even when its overall length remains constant. The critical concentration for monomer addition differs at the two ends: Cc(+) < Cc(−). When the free monomer concentration falls between these two values, net assembly occurs at the (+) end while net disassembly occurs at the (−) end—the hallmark of treadmilling.

CRITICAL CONCENTRATION FOR POLYMERIZATION

Cc=koff/konCc = k_off / k_on

Cc = critical concentration (monomer concentration at which rate of assembly equals rate of disassembly); koff = rate constant for subunit dissociation; kon = rate constant for subunit association. Because ATP hydrolysis occurs after incorporation, the effective koff at the (−) end is higher, producing a higher Cc at that end.

Microtubule Dynamic Instability

Microtubules exhibit dynamic instability, a behavior fundamentally different from treadmilling. Individual microtubules stochastically alternate between phases of steady growth and abrupt shrinkage (catastrophe), with occasional switches from shrinkage back to growth (rescue). The underlying mechanism involves a GTP cap at the (+) end: β-tubulin subunits are incorporated as GTP-bound dimers, and GTP hydrolysis lags behind polymerization. As long as a 'cap' of GTP-tubulin remains at the tip, the protofilaments maintain a straight conformation and the tubule grows. Loss of the GTP cap exposes GDP-tubulin, which adopts a curved conformation, destabilizing lateral contacts between protofilaments and triggering rapid depolymerization.

DYNAMIC INSTABILITY PARAMETERS

vgrowth,vshrinkage,fcat,frescuev_growth, v_shrinkage, f_cat, f_rescue

vgrowth = growth rate (µm/min); vshrinkage = shrinkage rate (typically much faster than growth); fcat = catastrophe frequency (transitions from growth to shrinkage per unit time); frescue = rescue frequency (transitions from shrinkage to growth per unit time). These four parameters fully characterize microtubule dynamic behavior in vitro.

Motor Protein Mechanochemistry

Motor proteins convert the free energy of ATP hydrolysis into directed mechanical displacement along cytoskeletal filaments. Conventional kinesin-1 is a processive, plus-end–directed microtubule motor that takes 8-nm steps—one per tubulin dimer—consuming one ATP per step. Cytoplasmic dynein moves toward the minus end and requires the dynactin complex for full processivity. Myosin II in muscle executes a power stroke upon release of phosphate (Pi) from its active site, sliding actin filaments past thick filaments in the sarcomere according to the sliding filament model.

FREE ENERGY OF ATP HYDROLYSIS

ΔG≈−50kJ/mol(undercellularconditions)ΔG ≈ −50 kJ/mol (under cellular conditions)

The standard free energy change for ATP → ADP + Pi is approximately −30.5 kJ/mol, but under physiological concentrations of ATP, ADP, and Pi in a typical cell, the actual ΔG is closer to −50 kJ/mol, providing ample energy for each mechanochemical step of a motor protein.

SECTION 5

Detailed Classification & Cell Motility Mechanisms

Cell motility encompasses diverse phenomena—crawling migration, ciliary and flagellar beating, and muscle contraction—all underpinned by cytoskeletal dynamics. The following diagram and table provide a systematic classification of motility mechanisms and the cytoskeletal elements responsible for each.

Cell Motility MechanismsCRAWLING MOTILITYLamellipodium1. Actin polymerization2. Adhesion to substrate3. Myosin II contraction4. Rear detachmentFocal adhesionCILIARY / FLAGELLAROuter doublet9+2 axonemeAxonemal dynein• MT sliding → bending• ATP-dependent dynein• Nexin links restrict slidingMUSCLE CONTRACTIONSarcomereZ-lineZ-lineActin (thin)Myosin (thick)• Sliding filament model• Cross-bridge cycling• Ca²⁺-regulated via troponinINTRACELLULAR TRANSPORT(−)(+)MicrotubuleVesicleKinesin →(+)Vesicle←(−) DyneinKinesin: anterograde (cell body → periphery)Dynein: retrograde (periphery → cell body)
Overview of major cell motility mechanisms. Crawling motility relies on actin polymerization-driven protrusion and myosin-based contraction. Ciliary/flagellar motility uses axonemal dynein to slide microtubule doublets. Muscle contraction employs myosin II cross-bridge cycling on actin thin filaments. Intracellular transport depends on kinesin (plus-end–directed) and dynein (minus-end–directed) motors on microtubule tracks.
Motility TypeCytoskeletal ElementMotor ProteinEnergy SourceExample
Cell crawlingActin microfilamentsMyosin IIATPNeutrophil chemotaxis
Ciliary beatingMicrotubules (9+2 axoneme)Axonemal dyneinATPTracheal epithelial cilia
Flagellar propulsionMicrotubules (9+2 axoneme)Axonemal dyneinATPSperm motility
Muscle contractionActin thin filamentsMyosin IIATPSkeletal, cardiac, smooth muscle
Vesicle transportMicrotubulesKinesin / DyneinATPAxonal transport in neurons
CytokinesisActin + myosin IIMyosin IIATPContractile ring in dividing cell
Chromosome segregationMicrotubules (spindle)Kinesin / Dynein + MT depolymerizationGTP/ATPAnaphase A and B

Summary of major cell motility and transport mechanisms with their cytoskeletal and motor protein requirements.

SECTION 6

Worked Example: Axonal Transport Velocity

Consider a clinical scenario in which a neuroscientist measures the rate of fast axonal transport of a fluorescently labeled vesicle along a motor neuron axon. The vesicle is observed to travel 24 µm in 30 seconds while moving in the anterograde direction. We want to determine the motor responsible, verify consistency with known stepping kinetics, and estimate ATP consumption.

Calculating Motor Protein Stepping Rate and ATP Consumption

  1. 1

    Step 1 — Determine transport velocity

    The vesicle traveled 24 µm in 30 s. Velocity = distance / time = 24 µm / 30 s = 0.8 µm/s. This falls within the typical range for fast axonal transport (0.5–5 µm/s), consistent with motor-driven rather than diffusion-based movement.
    v = 0.8 µm/s
  2. 2

    Step 2 — Identify the motor protein

    The direction is anterograde (cell body → axon terminal), meaning toward the (+) end of microtubules. The primary plus-end–directed microtubule motor is kinesin-1. Cytoplasmic dynein moves in the opposite direction (retrograde), so kinesin-1 is the responsible motor.
    Motor: Kinesin-1 (plus-end–directed)
  3. 3

    Step 3 — Calculate stepping rate

    Kinesin-1 takes discrete 8 nm steps, one per ATP hydrolyzed. Convert velocity to nm/s: 0.8 µm/s = 800 nm/s. Steps per second = 800 nm/s ÷ 8 nm/step = 100 steps/s. This is consistent with measured kinesin stepping rates of ~100 steps/s at saturating ATP concentrations.
    Stepping rate = 100 steps/s = 100 ATP/s
  4. 4

    Step 4 — Estimate total ATP consumed during the 30-second trip

    At 100 ATP molecules per second over 30 seconds: total ATP consumed = 100 × 30 = 3,000 ATP molecules for this single vesicle's journey. This illustrates why neurons, with their exceptionally long axons, have extremely high metabolic demands and are particularly vulnerable to mitochondrial dysfunction.
    Total ATP consumed ≈ 3,000 molecules per vesicle trip

SECTION 7

Pharmacological Disruption of the Cytoskeleton

Understanding cytoskeletal pharmacology is high-yield for the MCAT because numerous clinically significant drugs and toxins target actin filaments or microtubules. Because intermediate filaments lack the dynamic nucleotide-dependent behavior of the other two systems, they are not major pharmacological targets. The table below summarizes the most frequently tested agents.

AgentTargetMechanism of ActionClinical / Experimental Use
ColchicineTubulin dimersBinds free tubulin, preventing polymerization; arrests mitosis at metaphaseAcute gout; familial Mediterranean fever
Taxol (Paclitaxel)MicrotubulesStabilizes polymerized microtubules, preventing disassembly; blocks mitotic spindle dynamicsChemotherapy (breast, ovarian cancer)
Vincristine / VinblastineTubulin dimersVinca alkaloids that bind β-tubulin, inhibiting polymerization; arrest cells in M phaseChemotherapy (leukemia, lymphoma)
Cytochalasin DActin (+) endCaps barbed end of actin filaments, preventing new monomer additionResearch tool to study actin dynamics
PhalloidinF-actinStabilizes actin filaments, preventing depolymerization (analogous to taxol for microtubules)Fluorescent staining of actin in fixed cells; toxin from Amanita phalloides mushroom

Key cytoskeleton-targeting agents commonly tested on the MCAT.

🎯

MCAT STRATEGY NOTE

The unifying principle for cytoskeletal pharmacology is that rapidly dividing cells are most susceptible to agents that disrupt microtubule dynamics, because mitotic spindle assembly requires constant dynamic instability. Whether a drug prevents polymerization (colchicine, vinca alkaloids) or prevents depolymerization (taxol), the net effect is the same: the spindle cannot properly capture and segregate chromosomes, and the cell is arrested. This is why these agents serve as chemotherapeutic drugs—cancer cells divide far more frequently than most normal cells.

SECTION 8

Clinical Connections & Advanced Concepts

Cytoskeletal defects underlie numerous human diseases. Understanding these pathologies reinforces your knowledge of normal cytoskeletal function and provides the kind of integrative reasoning the MCAT rewards. For example, defects in dynein or the dynactin complex can impair retrograde axonal transport, contributing to neurodegenerative diseases; mutations in lamin A/C cause a spectrum of laminopathies including Emery-Dreifuss muscular dystrophy and Hutchinson-Gilford progeria syndrome; and mutations in keratin intermediate filament genes produce skin blistering disorders such as epidermolysis bullosa simplex.

Disease / ConditionCytoskeletal DefectMechanism
Kartagener syndromeAxonemal dynein (ciliary)Mutations in genes encoding dynein arms → immotile cilia → situs inversus, bronchiectasis, infertility
Epidermolysis bullosa simplexKeratin intermediate filamentsMutations in keratin 5 or keratin 14 → basal cell fragility → skin blistering with minor mechanical stress
Hutchinson-Gilford progeriaLamin A (nuclear IF)Aberrant splicing of LMNA gene → progerin → misshapen nuclei, premature aging phenotype
Alzheimer disease (tau)Microtubule-associated protein tauHyperphosphorylated tau dissociates from microtubules → neurofibrillary tangles → impaired axonal transport
Chédiak-Higashi syndromeLysosomal trafficking (microtubule-dependent)LYST gene mutation → defective vesicle trafficking → giant granules in leukocytes, immunodeficiency

Clinically significant cytoskeletal diseases.

Looking beyond the MCAT, advanced research frontiers include the role of septins as a fourth cytoskeletal system, the biophysics of mechanotransduction through the cytoskeleton-integrin-extracellular matrix axis, and the use of cryo-electron microscopy to resolve motor protein conformational changes at near-atomic resolution. The field continues to reveal how cells integrate chemical signaling with mechanical force generation—a theme central to developmental biology, immunology, and cancer biology.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A researcher treats cultured fibroblasts with cytochalasin D and observes that the cells lose their ability to crawl across a fibronectin-coated surface, yet intracellular vesicle trafficking appears unaffected. Explain why cytochalasin D selectively inhibits cell crawling without disrupting vesicle transport.
Show answer
Cytochalasin D caps the barbed (+) end of actin microfilaments, preventing new monomer addition and thereby halting actin polymerization-driven protrusion of lamellipodia and filopodia. Cell crawling depends critically on actin polymerization at the leading edge and myosin II-mediated contraction at the rear. Intracellular vesicle transport, however, relies primarily on microtubule-based motors (kinesin and dynein), which are unaffected by cytochalasin D. This selective disruption highlights the functional specialization of the two polar cytoskeletal systems: microfilaments for cortical mechanics and locomotion, microtubules for long-range cargo transport.

Question 2: BASIC CALCULATION

A single kinesin-1 molecule takes 8 nm steps along a microtubule, consuming one ATP per step. If the motor travels at 0.64 µm/s, how many ATP molecules does it consume per second?
Show answer
Convert the velocity to nanometers: 0.64 µm/s = 640 nm/s. Each step covers 8 nm and requires one ATP. Number of steps per second = 640 nm/s ÷ 8 nm/step = 80 steps/s. Since each step consumes one ATP, the motor hydrolyzes 80 ATP molecules per second. This calculation illustrates how processivity and ATP consumption are directly coupled in kinesin-1, a key concept for MCAT questions about motor protein energetics.

Question 3: INTERMEDIATE

A cell biologist measures microtubule dynamics in vitro and obtains the following parameters: vgrowth = 2 µm/min, vshrinkage = 15 µm/min, fcat = 0.02 events/s, frescue = 0.008 events/s. When colchicine is added, vgrowth drops to near zero while the other parameters remain initially unchanged. Predict what will happen to the average length of microtubules over time and explain the molecular basis.
Show answer
Colchicine binds free tubulin dimers and prevents their incorporation into microtubule protofilaments, effectively abolishing polymerization (v_growth → 0). Because catastrophe events still occur at the original frequency (f_cat = 0.02 events/s) and the shrinkage rate remains high (15 µm/min), microtubules that undergo catastrophe will shorten rapidly with no compensating growth phases. Furthermore, with no new GTP-tubulin being added, the protective GTP cap at the (+) end is lost more quickly, potentially increasing the effective catastrophe frequency. Over time, the net result is progressive depolymerization of the microtubule population. This is why colchicine arrests cells in mitosis: spindle microtubules cannot maintain their length and thus fail to capture kinetochores and generate the forces required for chromosome segregation.

Question 4: APPLIED

A patient presents with recurrent sinopulmonary infections, male infertility, and dextrocardia (heart on the right side). The physician suspects Kartagener syndrome (primary ciliary dyskinesia). Explain the molecular defect and why it produces this specific triad of symptoms. What cytoskeletal structure is affected, and which motor protein is deficient?
Show answer
Kartagener syndrome results from mutations affecting the outer (and sometimes inner) dynein arms of the 9+2 axonemal microtubule arrangement in cilia and flagella. Axonemal dynein is the motor protein that slides adjacent microtubule doublets relative to one another; when anchored by nexin links, this sliding is converted into bending, producing the characteristic wave-like beating pattern of cilia. Loss of functional dynein arms renders cilia immotile. The triad arises because: (1) immotile respiratory cilia cannot clear mucus from the airways, leading to recurrent sinopulmonary infections and eventual bronchiectasis; (2) immotile flagella on sperm prevent directed swimming, causing male infertility; and (3) during embryogenesis, nodal cilia generate a leftward flow of extraembryonic fluid that establishes left-right body asymmetry—without functional nodal cilia, organ laterality is randomized, and approximately 50% of affected individuals have situs inversus (including dextrocardia).

Question 5: CRITICAL THINKING

Both taxol and vinca alkaloids are used as chemotherapeutic agents that target microtubules, yet they have opposite biochemical mechanisms—taxol stabilizes microtubules while vinca alkaloids prevent their assembly. Construct a unified mechanistic explanation for why both classes of drugs effectively arrest mitosis, despite their opposing effects on microtubule polymer mass. Consider the concept of dynamic instability in your answer.
Show answer
The key insight is that proper mitotic spindle function requires not merely the presence of microtubules but their capacity for dynamic instability—the stochastic switching between growth and catastrophe at the (+) end. During mitosis, spindle microtubules must search three-dimensional space to capture kinetochores (the 'search and capture' model), generate pulling forces through coordinated depolymerization at kinetochore-attached ends, and satisfy the spindle assembly checkpoint before anaphase onset. Vinca alkaloids abolish dynamic instability by depleting the pool of polymerization-competent tubulin, causing net depolymerization of existing microtubules—spindle assembly fails. Taxol abolishes dynamic instability from the opposite direction: by stabilizing the polymer lattice and preventing catastrophes, microtubules become 'frozen' in a static configuration. Although polymer mass is actually increased, the spindle cannot remodel itself, cannot correct erroneous attachments, and cannot generate the depolymerization-driven forces needed for chromosome movement. Both drugs thus converge on the same functional outcome—suppression of dynamic instability—and the spindle assembly checkpoint prevents entry into anaphase, effectively arresting cells in a pseudo-metaphase state. This unified framework explains why both pro-polymerization and anti-polymerization agents are effective anticancer strategies: any pharmacological perturbation that disrupts the finely tuned balance of microtubule dynamics will halt cell division.

SUMMARY

Lesson Summary

Summary

The eukaryotic cytoskeleton consists of three polymer systems: microfilaments (7 nm, actin, ATP-dependent, polar), microtubules (25 nm, αβ-tubulin, GTP-dependent, polar), and intermediate filaments (10 nm, tissue-specific proteins, no nucleotide, nonpolar). Microfilaments undergo treadmilling and are critical for cell crawling, cytokinesis, and cortical mechanics, working in concert with myosin motors. Microtubules exhibit dynamic instability controlled by a GTP cap and serve as tracks for kinesin (plus-end–directed) and dynein (minus-end–directed) motors. IFs provide passive mechanical resilience without associated motor proteins.

Cell motility mechanisms include actin-based cell crawling, dynein-driven ciliary and flagellar beating (9+2 axoneme), and muscle contraction via the sliding filament model. Pharmacological agents that target the cytoskeleton—colchicine, taxol, vinca alkaloids, cytochalasin D, and phalloidin—exploit the dynamic nature of these polymers, particularly the requirement for dynamic instability during mitotic spindle assembly. Clinical diseases such as Kartagener syndrome, epidermolysis bullosa simplex, and Alzheimer disease illustrate how cytoskeletal dysfunction translates into human pathology.

Varsity Tutors • MCAT Biological & Biochemical Foundations of Living Systems • Cytoskeleton Structure and Cell Motility (2A)